Kannu Bansal
Worcester, MANPI 1174194419
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.4%), speaking fees and education — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Medtronic at 45.1% of the total. 2025 is the largest year on record at $5,875, more than ten times the $154 reported in 2021.
Across 154 payments — averaging $52.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Abiomed$841
- Amgen$587
- Abbott$431
- Gilead$343
- E.r. Squibb & Sons, L.L.C.$312
- plus $2K from 23 others
What the payments were for
- Speaking & faculty fees$3,05938%
- Travel & lodging$2994%
- Food & beverage$3,77646%
- Education$1,01212%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 4 | $3,674 |
| Abiomed | 13 | $841 |
| Amgen | 21 | $587 |
| Abbott | 4 | $431 |
| Gilead | 14 | $343 |
| E.r. Squibb & Sons, L.L.C. | 14 | $312 |
| Boehringer Ingelheim | 12 | $304 |
| AstraZeneca(2 entities) | 10 | $205 |
| AbbVie | 6 | $184 |
| Bayer | 7 | $145 |
| Pfizer | 5 | $124 |
| Boston Scientific | 4 | $123 |
| Novartis | 7 | $122 |
| Scpharmaceuticals Inc. | 5 | $116 |
| Lexicon Pharmaceuticals, Inc. | 1 | $82 |
| Alnylam Pharmaceuticals Inc. | 3 | $74 |
| Kiniksa Pharmaceuticals International, PLC | 4 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| Lantheus Medical Imaging, Inc. | 2 | $52 |
| Karyopharm Therapeutics Inc. | 3 | $50 |
| GSK | 3 | $43 |
| Viiv Healthcare Company | 1 | $32 |
| Penumbra, Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Bridgebio Pharma, Inc. | 2 | $29 |
| Esperion Therapeutics, Inc. | 2 | $28 |
| Novo Nordisk | 1 | $23 |
| Johnson & Johnson | 1 | $21 |
| Alcresta Therapeutics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.